LEONI, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 216
EU - Europa 169
AS - Asia 164
SA - Sud America 11
AF - Africa 10
Totale 570
Nazione #
US - Stati Uniti d'America 212
CN - Cina 56
GB - Regno Unito 52
SG - Singapore 45
IT - Italia 31
SE - Svezia 24
VN - Vietnam 24
FR - Francia 14
DE - Germania 12
IN - India 12
IE - Irlanda 9
BR - Brasile 8
RU - Federazione Russa 8
JP - Giappone 7
HK - Hong Kong 6
NL - Olanda 6
EE - Estonia 4
QA - Qatar 4
TG - Togo 4
ZA - Sudafrica 4
CA - Canada 3
CH - Svizzera 3
EC - Ecuador 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
EG - Egitto 1
ES - Italia 1
FI - Finlandia 1
HN - Honduras 1
IQ - Iraq 1
JO - Giordania 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 570
Città #
Southend 47
Singapore 25
Ashburn 22
Chandler 19
Beijing 18
Fairfield 15
San Jose 14
Santa Clara 14
Houston 12
Seattle 11
Ho Chi Minh City 10
Dublin 9
Woodbridge 9
Princeton 8
Wilmington 7
Hanoi 6
Hong Kong 6
Los Angeles 6
Bologna 5
Cambridge 5
Lauterbourg 5
Boardman 4
Bremen 4
Doha 4
Lomé 4
Medford 4
Nanjing 4
Padova 4
San Diego 4
Tokyo 4
Turin 4
Westminster 4
Chicago 3
Ann Arbor 2
Bhopal 2
Changsha 2
Guangzhou 2
Hebei 2
Milan 2
Redwood City 2
Saint Petersburg 2
Shenyang 2
Svilajnac 2
São Paulo 2
Toronto 2
Ōtemae 2
Amman 1
Angono 1
Atlanta 1
Baghdad 1
Bangkok 1
Bari 1
Basingstoke 1
Belo Horizonte 1
Birmingham 1
Bom Jardim 1
Buffalo 1
Bắc Giang 1
Cairo 1
Castellammare di Stabia 1
Cuenca 1
Da Nang 1
Drummondville 1
Duque de Caxias 1
Florence 1
Foshan 1
Helsinki 1
Hải Dương 1
Jiaxing 1
Juneau 1
Memphis 1
Milwaukee 1
Monte Grande 1
Moscow 1
Mountain View 1
Nanchang 1
New Delhi 1
New York 1
Ningbo 1
Norwalk 1
Orem 1
Poggio Renatico 1
Quito 1
Redondo Beach 1
Ribeirão das Neves 1
Rome 1
Samarkand 1
San Pedro Sula 1
Sertão Santana 1
Silang 1
Stockholm 1
Suzhou 1
Taichung 1
Teramo 1
Tunis 1
Uberlândia 1
Udon Thani 1
Wuhan 1
Xuzhou 1
Yubileyny 1
Totale 400
Nome #
HIGH RATE OF COMPLETE HEMATOLOGICAL RESPONSE IN ELDERLY PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS BY INNOVATIVE SEQUENTIAL USE OF NILOTINIB AND IMATINIB: A GIMEMA CLINICAL TRIAL LAL 1408 158
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse. 156
Extremely high rate of complete hematological response of elderly Ph+ acute lymphoblastic leukemia (ALL) patients by innovative sequential use of Nilotinib and Imatinib. A GIMEMA Protocol LAL 1408 136
Sequential use of first and second generation TKIs are effective on prolonged overall survival in elderly population affected by Ph+ acute lymphoblastic leukemia: the GIMEMA experience 128
Totale 578
Categoria #
all - tutte 1.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/202270 4 0 3 5 7 5 0 7 6 4 17 12
2022/202380 5 6 5 10 8 7 2 10 16 5 6 0
2023/202419 1 3 1 2 1 0 5 0 3 0 2 1
2024/202577 7 9 10 6 18 5 4 0 2 5 2 9
2025/2026167 12 10 15 5 24 7 13 9 49 19 2 2
Totale 578